<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924804</url>
  </required_header>
  <id_info>
    <org_study_id>20190418</org_study_id>
    <nct_id>NCT03924804</nct_id>
  </id_info>
  <brief_title>Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery.</brief_title>
  <official_title>Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the trial was to explore the effect of different infusion volume on
      perioperative bladder and blood volume in patients undergoing daytime surgery assisted by
      bladder and vascular ultrasound and transthoracic echocardiography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the trial was to evaluate the effects of different infusion volume of
      Ringer's solution acetate (2 ml/kg,8ml/kg, 16ml/kg) on bladder volume,
      hemodynamics,transthoracic echocardiography and vascular ultrasound including the inferior
      vena cava(IVC) and the right subclavian vein(SCV) diameter and the IVC and SCV collapsibility
      index in patients undergoing daytime surgery through a randomized controlled clinical study,
      so as to provide better guidance for clinical transfusion avoiding bladder catheterization .
      The patients in this trial were visited before induction and discharge from the
      postanaesthesia .We also collected the first time and times of micturition and whether the
      patients have the dysuria.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Doppler Ultrasonography Assessed Bladder and Blood Volume</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1. The change of bladder volume</measure>
    <time_frame>baseline and 10 minutes before leaving the post-anesthesia care unite</time_frame>
    <description>bladder and blood volume in patients undergoing daytime surgery assisted by bladder and vascular ultrasound</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cholecystolithiasis and Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Group A: 2 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: 8 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C: 16 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 2 ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group A: 2 ml/kg group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 8ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group B: 8 ml/kg group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 16ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group C: 16 ml/kg group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. ethnic Chinese;

          -  2. age, 18 to 65 years old;

          -  3. American Society of Anaesthesiologists (ASA) physical status I or II;

          -  4. Daytime patients scheduled for general anesthesia

        Exclusion Criteria:

          -  Patients unwilling to cooperate with the experiment

          -  Body mass index exceeding 30 kg/m2;

          -  Patients with a history of heart ,liver and Renal failure ,hypertension,diabetes
             mellitus or arteriosclerosis; and any allergy to drugs used in the study.

          -  Patients with the urinary diseases, such as kidney, ureteral calculi and tumors,
             prostatic hypertrophy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wen-fei Tan, M.D.,PhD</last_name>
    <phone>024-83283100</phone>
    <email>winfieldtan@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-fei Tan, M.D.,Ph.D</last_name>
      <phone>024-83283100</phone>
      <email>winfieldtan@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

